Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Dynavax Technologies (NQ: DVAX ) 11.99 +0.20 (+1.70%) Streaming Delayed Price Updated: 11:54 AM EST, Nov 5, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Press Releases about Dynavax Technologies Lantheus Appoints Julie Eastland as New Board Member September 05, 2024 From Lantheus Holdings, Inc. Via GlobeNewswire Clover Provides Updates on COVID-19 Vaccine Commercial Launch and Strategic Priorities in 2023 January 15, 2023 From Clover Biopharmaceuticals Via GlobeNewswire Clover’s Vaccine Candidate Reduced Household Transmission of SARS-CoV-2 in Study Published in Clinical Infectious Diseases November 30, 2022 From Clover Biopharmaceuticals Via GlobeNewswire Clover Provides Update on 2022 Corporate Milestones October 09, 2022 From Clover Biopharmaceuticals Via GlobeNewswire Global Antibiotic Resistance Market to Hit US$16.5 Billion By 2030 April 21, 2022 FN Media Group Presents Microsmallcap.com Market Commentary New York, NY – April 21, 2022 – Resistance to antibiotics is a growing concern. About 750,000 people die each year worldwide from... Via FinancialNewsMedia Scientific Reports Revealing Early Promise for Universal Coronavirus Vaccine October 20, 2021 Palm Beach, FL – October 20, 2021 – FinancialNewsMedia.com News Commentary – Recently, scientific reports have shown that a universal coronavirus vaccine that protects against COVID-19 causing... Via FinancialNewsMedia Exposures COVID-19 As the Virus Continues, the Global Covid-19 Vaccine Market Expected to Reach $25 Billion By 2024 September 23, 2021 Via FinancialNewsMedia Exposures COVID-19 Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
